Male# | Female¶ | |||||
GLI 2012 | ECSC/ERS | NHANES III | GLI 2012 | ECSC/ERS | NHANES III | |
Obstruction | 33.3 | 31.1 | 34.5 | 25.4 | 24.7 | 27.9 |
Obstruction and FEV1<LLN | 26.4 | 22.7 | 27.6 | 20.4 | 15.7 | 22.1 |
Obstruction and FVC>LLN | 21.2 | 22.5 | 19.2 | 15.6 | 20.0 | 15.1 |
FVC<LLN | 29.1 | 20.9 | 37.9 | 27.8 | 12.8 | 35.5 |
Restrictive pattern | 17.1 | 12.3 | 22.6 | 18.1 | 8.1 | 22.8 |
Mixed pattern | 12.1 | 8.6 | 15.3 | 9.7 | 4.7 | 12.7 |
Data are presented as %. All prevalence rates differ significantly (p<0.019) from Global Lung Initiative (GLI) 2012, except for overall obstruction between GLI 2012 and NHANES (National Health and Nutrition Examination Survey) III in males. Obstruction: FEV1/FVC<LLN; restrictive pattern: FVC<LLN and FEV1/FVC>LLN; mixed pattern: FEV1/FVC<LLN and FVC<LLN; ECSC: European Community for Steel and Coal; ERS: European Respiratory Society. #: n=8870; ¶: n=8707.